Impact of hyperlipidemia and statins on ischemic stroke outcomes after intra-arterial fibrinolysis and percutaneous mechanical embolectomy

Cerebrovascular Diseases

Volumn 28, Issue 4, 2009, Pages 384-390

  Restrepo, Lucas ^a   Bang, Oh Young ^c   Ovbiagele, Bruce ^a   Ali, Latisha ^a   Kim, Doojin ^a   Liebeskind, David S ^a   Starkman, Sidney ^a,b   Vinuela, Fernando ^a   Duckwiler, Gary R ^a   Jahan, Reza ^a   Saver, Jeffrey L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Emergency Medicine ^*

^c Sungkyunkwan University   (South Korea)

Author keywords

Hyperlipidemia; Ischemic stroke; Percutaneous embolectomy; Statins; Thrombolysis

Indexed keywords

ALTEPLASE; ATORVASTATIN; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROUROKINASE; WARFARIN;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CHI SQUARE TEST; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; DIABETES MELLITUS; DRUG EFFECT; FEMALE; FIBRINOLYSIS; FUNCTIONAL ASSESSMENT; GROUPS BY AGE; HUMAN; HYPERLIPIDEMIA; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MECHANICAL THROMBECTOMY; MEDICAL INSTRUMENTATION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE; PERCUTANEOUS THROMBECTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANK SUM TEST; RECANALIZATION; REVASCULARIZATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CHOLESTEROL; EMBOLECTOMY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; INTRACRANIAL HEMORRHAGES; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 69149100802     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235625     Document Type: Article

References (29)

1. Alexandrov AV, Demchuk AM, Felberg RA, Christou I, Barber PA, Burgin WS, et al: High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial Doppler monitoring. Stroke 2000; 31: 610-614
2. Christou I, Alexandrov AV, Burgin WS, Wojner AW, Felberg RA, Malkoff M, et al: Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke. Stroke 2000; 31: 1812-1816
3. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke.. N Engl J Med 1995; 333: 1581-1587
4. Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al: Guidelines for the Early Management of Adults with Ischemic Stroke: a guideline from AHA/ASA Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke 2007; 38: 1655-1711
5. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al; ECASS Inves- tigators: Thrombolysis with alteplase 3 to 45 h after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329
6. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al: Intra-arterial pro- urokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999; 282: 2003-2011
7. Ogawa A, Mori E, Minematsu K, Taki W, Takahashi A, Nemoto S, et al; MELT Japan Study Group: Randomized trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007; 38: 2633-2639
8. Kim D, Jahan R, Starkman S, Abolian A, Kidwell CS, Vinuela F, et al: Endovascular mechanical clot retrieval in a broad ischemic stroke cohort. AJNR 2006; 27: 2048-2052
9. Jahan R, Duckwiler GR, Kidwell CS, Sayre JW, Gobin YP, Villablanca JP, et al: Intra-arterial thrombolysis for treatment of acute stroke: experience in 26 patients with longterm follow-up. AJNR Am J Neuroradiol 1999; 20: 1291-1299
10. Gobin YP, Starkman S, Duckwiler GR, Grobelny T, Kidwell CS, Jahan R, et al: Merci 1: A phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 2004; 35: 2848-2854
11. Amarenco P, Bogousslavsky J, Callahan A, Goldstein LB, Hennerici M, Rudolph AE, et al; Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators: High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549-559
12. Paciaroni M, Hennerici M, Agnelli G, Bogousslavsky J: Statins and stroke prevention. Cerebrovasc Dis 2007; 24: 170-182
13. La Rosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al; Treating to New Targets (TNT) Investigators: Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352: 1425-1435
14. Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, et al: Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes - the MIRACL study: A randomized controlled trial. JAMA 2001; 285: 1711-1718
15. Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, et al; Veterans Affairs High-Density Lipoprotein Intervention Trial: Relation of gemfibrozil treatment and lipid levels with major coronary events - VA-HIT: a randomized controlled trial. JAMA 2001; 285: 1585-1591
16. Ovbiagele B, Saver JL, Fredieu A, Suzuki S, Selco S, Rajajee V, et al: In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke 2004; 35: 2879-2883
17. Vauthey C, de Freitas GR, van Melle G, Devuyst G, Bogousslavsky J: Better outcome after stroke with higher serum cholesterol levels. Neurology 2000; 54: 1944-1949
18. Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM; FASTER Investigators: Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): A randomised controlled pilot trial. Lancet Neurol 2007; 6: 961-969
19. Colivicchi F, Bassi A, Santini M, Caltagirone C: Discontinuation of statin therapy and clinical outcome after ischemic stroke. Stroke 2007; 38: 2652-2657
20. Heart Protection Collaborative Study Group: Effects of cholesterol-lowering with simva- statin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004; 363: 757-767
21. Alvarez-Sabin J, Huertas R, Quintana M, Rubiera M, Delgado P, Ribo M, et al: Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator. Stroke 2007; 38: 1076-1078
22. Bang OY, Saver JL, Liebeskind DS, Starkman S, Villablanca P, Salamon N, et al: Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology 2007; 68: 737-742
23. TIMI Study group: Special report: The Thrombolysis in Myocardial Infarction (TIMI) trial. N Engl J Med 1985; 312: 932-936
24. Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, et al: Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by nitric oxide synthase. Proc Natl Acad Sci USA 1998; 95: 8880-8885
25. Vaughan CJ, Delanty N: Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 1999; 30: 1969-1973
26. Chen J, Li Y, Zhang ZG, Wang L, Wang Y, Jiang H, et al: HMG-CoA reductase inhibitor induces angiogenesis, neurogenesis, synaptogenesis and improves functional outcome after stroke. Ann Neurol 2003; 53: 743-751
27. Ovbiagele B, Saver JL, Starkman S, Kim D, Ali LK, Jahan R, et al: Statin enhancement of collateralization in acute stroke. Neurology 2007; 68: 2129-2131
28. Marti-Fabregas J, Gomis M, Arboix A, Aleu A, Pagonabarraga J, Belvis R, et al: Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke 2004; 35: 1117-1121
29. Moonis M, Kane K, Schwiderski U, Sandage BW, Fisher M: HMG-CoA Reductase inhibitors improve acute ischemic stroke outcome. Stroke 2005; 36: 1298